Program of heart transplantation autologous. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Heart Myocardium Venae Cavae Endocardium Heart Atria Allografts T-Lymphocytes Antilymphocyte Serum Fetal Heart Heart Valves Cells, Cultured Hematopoietic Stem Cells Heart Ventricles Coronary Vessels Myocytes, Cardiac Transplants Kidney Vena Cava, Inferior Bone Marrow Cells Stem Cells Liver Bone Marrow

Organisms4

Transplantation Chimera Rats, Inbred Lew Mice, Inbred C57BL Mice, Inbred BALB C

Diseases56

Heart Failure Cardiomyopathy, Dilated Postoperative Complications Heart Diseases Heart Defects, Congenital Cardiomyopathies Cardiomyopathy, Restrictive Graft vs Host Disease Recurrence Primary Graft Dysfunction Acute Disease Chronic Disease Infection Myocarditis Liver Failure Amyloidosis Brain Death Sinus Arrest, Cardiac Ventricular Dysfunction, Left Hematologic Neoplasms Cytomegalovirus Infections Protein-Losing Enteropathies Cardio-Renal Syndrome Cardiac Output, Low Coronary Disease Multiple Myeloma Myocardial Ischemia Blood Group Incompatibility Heart Failure, Systolic Hypoplastic Left Heart Syndrome Chagas Cardiomyopathy Kidney Failure, Chronic Lymphoma, Non-Hodgkin Cadaver Cardiac Output, High Leukemia Disease Progression Renal Insufficiency Disease Models, Animal Liver Diseases Shock, Cardiogenic Tachycardia, Ectopic Atrial Ventricular Remodeling Hodgkin Disease Vascular Diseases Ventricular Dysfunction, Right Myocardial Infarction Heart Block Leukemia, Myeloid, Acute Myocardial Reperfusion Injury Coronary Artery Disease Cardiac Complexes, Premature Anemia, Aplastic Cardiomyopathy, Hypertrophic Bronchiolitis Obliterans Death, Sudden, Cardiac

Chemicals and Drugs26

Immunosuppressive Agents Cyclosporine HLA Antigens Tacrolimus Melphalan ABO Blood-Group System Isoantibodies Mycophenolic Acid Antilymphocyte Serum Cyclophosphamide Biological Markers Busulfan Azathioprine Cardiotonic Agents Cyclosporins Carmustine Myeloablative Agonists Antigens, CD34 Etoposide Creatinine Natriuretic Peptide, Brain Granulocyte Colony-Stimulating Factor Cytarabine Ephedrine Adrenergic beta-Antagonists Antibodies, Monoclonal

Analytical, Diagnostic and Therapeutic Techniques and Equipment108

Heart Transplantation Transplantation, Autologous Transplantation, Homologous Liver Transplantation Heart-Assist Devices Kidney Transplantation Bone Marrow Transplantation Hematopoietic Stem Cell Transplantation Treatment Outcome Transplantation, Heterotopic Stem Cell Transplantation Heart Rate Lung Transplantation Retrospective Studies Transplantation Conditioning Follow-Up Studies Program Evaluation Organ Transplantation Transplantation Immunosuppression Heart-Lung Transplantation Blood Transfusion, Autologous Survival Rate Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Postoperative Period Survival Analysis Transplantation, Isogeneic Heart, Artificial Risk Factors Prospective Studies Donor Selection Histocompatibility Testing Prognosis Peripheral Blood Stem Cell Transplantation Organ Preservation Patient Selection Biopsy Cord Blood Stem Cell Transplantation Combined Modality Therapy Postoperative Care Assisted Circulation Blood Grouping and Crossmatching Extracorporeal Membrane Oxygenation Kaplan-Meier Estimate Echocardiography Anastomosis, Surgical Heart Function Tests Whole-Body Irradiation Cardiomyoplasty Skin Transplantation Mesenchymal Stem Cell Transplantation Risk Assessment Predictive Value of Tests Fetal Tissue Transplantation Cardiovascular Surgical Procedures Incidence Stroke Volume Transplantation, Heterologous Actuarial Analysis Tissue Transplantation Severity of Illness Index Multivariate Analysis Reoperation Feasibility Studies Cohort Studies Exercise Test Remission Induction Proportional Hazards Models Registries Corneal Transplantation Bloodless Medical and Surgical Procedures Preoperative Care Fatal Outcome Antineoplastic Combined Chemotherapy Protocols Cardiac Catheterization Models, Animal Disease-Free Survival Bone Marrow Purging Fontan Procedure Immunohistochemistry Hematopoietic Stem Cell Mobilization Cause of Death Disease Models, Animal Brain Tissue Transplantation Pilot Projects Salvage Therapy Facial Transplantation Statistics, Nonparametric Analysis of Variance Intra-Aortic Balloon Pumping Tissue and Organ Harvesting Preoperative Period Electrocardiography Lymphocyte Culture Test, Mixed Cardiac Surgical Procedures Case-Control Studies Cardiac Pacing, Artificial Sensitivity and Specificity Ultrasonography, Interventional Chi-Square Distribution Drug Therapy, Combination Lymphocyte Activation Treatment Failure Flow Cytometry Cell Separation Risk

Phenomena and Processes25

Graft Rejection Graft Survival Heart Rate Time Factors Transplantation Immunology Hemodynamics Transplantation Tolerance Histocompatibility Ventricular Function, Left Stroke Volume Myocardial Contraction Cell Differentiation Oxygen Consumption Ventricular Remodeling Pulmonary Wedge Pressure Recovery of Function Vascular Resistance Immunocompromised Host Time Sensitivity and Specificity Dose-Response Relationship, Drug Chi-Square Distribution Lymphocyte Activation Cytotoxicity, Immunologic Risk

Disciplines and Occupations3

Immunohistochemistry Outcome Assessment (Health Care)Nursing

Anthropology, Education, Sociology and Social Phenomena2

Government Programs Quality of Life

Humanities2

Jehovah's Witnesses Quality of Life

Information Science5

Survival Rate Incidence Registries Fatal Outcome Cause of Death

Named Groups4

Tissue Donors Living Donors Infant, Newborn Jehovah's Witnesses

Health Care48

Treatment Outcome Waiting Lists Retrospective Studies Follow-Up Studies Tissue and Organ Procurement Program Evaluation Survival Rate Postoperative Period Survival Analysis Risk Factors Prospective Studies Donor Selection Program Development Patient Selection Postoperative Care Kaplan-Meier Estimate Risk Assessment Predictive Value of Tests Incidence Actuarial Analysis Severity of Illness Index Multivariate Analysis Feasibility Studies Age Factors Cohort Studies Proportional Hazards Models Registries Bloodless Medical and Surgical Procedures Preoperative Care Fatal Outcome Disease-Free Survival Cause of Death American Heart Association Pilot Projects Cardiac Care Facilities Statistics, Nonparametric Analysis of Variance Preoperative Period National Health Programs Case-Control Studies Outcome Assessment (Health Care)Sensitivity and Specificity Chi-Square Distribution Nursing Sex Factors Treatment Failure Health Promotion Risk

Geographicals2

United States Spain

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Heart Transplantation Transplantation, Autologous Transplantation, Homologous Liver Transplantation Heart Graft Rejection Heart-Assist Devices Kidney Transplantation Bone Marrow Transplantation Heart Failure Hematopoietic Stem Cell Transplantation Tissue Donors Graft Survival Treatment Outcome Transplantation, Heterotopic Stem Cell Transplantation Heart Rate Lung Transplantation Cardiomyopathy, Dilated Time Factors Immunosuppressive Agents Waiting Lists Retrospective Studies Transplantation Conditioning Follow-Up Studies Tissue and Organ Procurement Postoperative Complications Program Evaluation Organ Transplantation Heart Diseases Transplantation Heart Defects, Congenital Transplantation Immunology Immunosuppression Heart-Lung Transplantation Blood Transfusion, Autologous Cardiomyopathies Survival Rate Cell Transplantation Pancreas Transplantation Islets of Langerhans Transplantation Postoperative Period Cyclosporine Myocardium Survival Analysis Transplantation, Isogeneic Heart, Artificial Risk Factors Cardiomyopathy, Restrictive Transplantation Chimera Prospective Studies Donor Selection Graft vs Host Disease Histocompatibility Testing Prognosis Peripheral Blood Stem Cell Transplantation Hemodynamics Program Development Transplantation Tolerance Recurrence Organ Preservation Patient Selection Rats, Inbred Lew Living Donors Biopsy United States Cord Blood Stem Cell Transplantation Combined Modality Therapy Venae Cavae Postoperative Care Assisted Circulation Histocompatibility Blood Grouping and Crossmatching Extracorporeal Membrane Oxygenation Endocardium HLA Antigens Kaplan-Meier Estimate Primary Graft Dysfunction Echocardiography Acute Disease Tacrolimus Chronic Disease Ventricular Function, Left Heart Atria Anastomosis, Surgical Heart Function Tests Whole-Body Irradiation Infection Cardiomyoplasty Skin Transplantation Mesenchymal Stem Cell Transplantation Myocarditis Risk Assessment Liver Failure Amyloidosis Predictive Value of Tests Fetal Tissue Transplantation Brain Death Sinus Arrest, Cardiac Cardiovascular Surgical Procedures

No FAQ available that match "program of heart transplantation autologous"